SBI Securities’s Exact Sciences EXAS Stock Holding History

SBI Securities’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-826	Closed	-$83.9K	–	4070
2025 Q4	$83.9K	Sell	826 -216	-21%	-$17.3K	﹤0.01%	902
2025 Q3	$57K	Sell	1,042 -126	-11%	-$6.3K	﹤0.01%	1038
2025 Q2	$62.1K	Sell	1,168 -7	-0.6%	-$356	﹤0.01%	976
2025 Q1	$50.9K	Sell	1,175 -8	-0.7%	-$405	﹤0.01%	978
2024 Q4	$66.5K	Buy	+1,183	New	+$73.6K	﹤0.01%	889

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

SBI Securities's EXAS Position: Q1 2026 in Review

SBI Securities sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 826 shares — an estimated $83.9K sold.

SBI Securities first reported a position in EXAS in Q4 2024 and held it in 5 quarters. The position peaked at $83.9K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

SBI Securities reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
SBI Securities sold 826 Exact Sciences shares in Q1 2026, an estimated $83.9K.
SBI Securities first reported a position in Exact Sciences in Q4 2024 and held it in 5 quarters.
SBI Securities's Exact Sciences position peaked at $83.9K in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.